Clinical Trial Update: The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

A neoadjuvant combined hormone therapy trial is being conducted in premenopausal women with locally advanced ER+/HER2- breast cancer in Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary | Conditions: The Neoadjuvant Therapy | Phase 2, Phase 3 | Status: UNKNOWN